Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))

B. Govindarajan; M. C. Mizesko; M. S. Miller; H. Onda; M. Nunnelley; K. Casper; D. Brat; C. Cohen; J. L. Arbiser

Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))

B. Govindarajan, M. C. Mizesko, M. S. Miller, H. Onda, M. Nunnelley, K. Casper, D. Brat, C. Cohen, J. L. Arbiser

Pathology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	5053
Number of pages	1
Journal	Clinical Cancer Research
Volume	9
Issue number	13
State	Published - Oct 15 2003

ASJC Scopus subject areas

Cancer Research
Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Govindarajan, B., Mizesko, M. C., Miller, M. S., Onda, H., Nunnelley, M., Casper, K., Brat, D., Cohen, C., & Arbiser, J. L. (2003). Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475)). Clinical Cancer Research, 9(13), 5053.

Govindarajan, B. ; Mizesko, M. C. ; Miller, M. S. et al. / Erratum : Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475)). In: Clinical Cancer Research. 2003 ; Vol. 9, No. 13. pp. 5053.

@article{d7095e4bcbad42d18baff805a711aff1,

title = "Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))",

author = "B. Govindarajan and Mizesko, {M. C.} and Miller, {M. S.} and H. Onda and M. Nunnelley and K. Casper and D. Brat and C. Cohen and Arbiser, {J. L.}",

year = "2003",

month = oct,

day = "15",

language = "English (US)",

volume = "9",

pages = "5053",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "13",

}

Govindarajan, B, Mizesko, MC, Miller, MS, Onda, H, Nunnelley, M, Casper, K, Brat, D, Cohen, C & Arbiser, JL 2003, 'Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))', Clinical Cancer Research, vol. 9, no. 13, pp. 5053.

Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475)). / Govindarajan, B.; Mizesko, M. C.; Miller, M. S. et al.
In: Clinical Cancer Research, Vol. 9, No. 13, 15.10.2003, p. 5053.

Research output: Contribution to journal › Comment/debate › peer-review

TY - JOUR

T1 - Erratum

T2 - Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))

AU - Govindarajan, B.

AU - Mizesko, M. C.

AU - Miller, M. S.

AU - Onda, H.

AU - Nunnelley, M.

AU - Casper, K.

AU - Brat, D.

AU - Cohen, C.

AU - Arbiser, J. L.

PY - 2003/10/15

Y1 - 2003/10/15

UR - http://www.scopus.com/inward/record.url?scp=0142188123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0142188123&partnerID=8YFLogxK

M3 - Comment/debate

AN - SCOPUS:0142188123

SN - 1078-0432

VL - 9

SP - 5053

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 13

ER -

Govindarajan B, Mizesko MC, Miller MS, Onda H, Nunnelley M, Casper K et al. Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475)). Clinical Cancer Research. 2003 Oct 15;9(13):5053.

Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475))

ASJC Scopus subject areas

UN SDGs

Other files and links

Cite this